Promotus is actively building a distributor network to bring KneeMD to doctor’s offices, physical therapy clinics and patients nationwide.
Promotus is actively building a distributor network to bring KneeMD to doctor’s offices, physical therapy clinics and patients nationwide.
A Growing Market
Primary Market
By 2015, an estimated 1.4 million total knee arthroplasties (TKAs, or total knee replacements) will be performed each year in the U.S.1 Research has shown that nearly 15% of TKAs fail or require revision due to arthrofibrosis, a complication where an excessive scar tissue response leads to painful restriction of joint motion that persists despite rehabilitation exercises and stretching.2 KneeMD is designed to promote improvements in range of motion and stretch in extension for these patients.
Secondary Market
By 2015, an estimated 1.4 million total knee arthroplasties (TKAs, or total knee replacements) will be performed each year in the U.S.1 Research has shown that nearly 15% of TKAs fail or require revision due to arthrofibrosis, a complication where an excessive scar tissue response leads to painful restriction of joint motion that persists despite rehabilitation exercises and stretching.2 KneeMD is designed to promote improvements in range of motion and stretch in extension for these patients.
2010 TKA with short term extension deficit: 30%**
2010 TKA with long term extension deficit: 8–12%***
* Journal of Bone & Joint Surgery. “Projections of Primary and Revision Hip and Knee Arthroplasty in the United States 2005 to 2030” (2007; 89:780-5. doi:10.2106/JBJS.F.00222)
** Extrapolated and averaged based on interviews with several Surgeons, Physician Assistants, and Physical Therapists specializing in total knee arthroplasty
*** Journal of the American Academy of Orthopaedic Surgeons. “Stiffness After Total Knee Arthroplasty”, Matthew R. Bong, MD, and Paul E. Di Cesare, MD
A Differentiated Product
Existing treatment for TKA patients who have not achieved at least 0° of extension by the seventh post-operative day involves physical therapy modalities targeted at gradual stretching, including hanging weights, extension boards and drop-out casts. The efficacy of these treatments varies depending on the amount of scar tissue present.
KneeMD is different because it is an easy to use, portable device that puts patients in control of their rehabilitation. Post-operative knee patients can effectively stretch and rotate their own knees – at home, on the road and even in the pool – without the aid of a physical therapist. Patients can also adjust the frequency, duration and intensity of therapy so they can work on their rehabilitation on their own schedule, with less pain.
Orthopedic surgeons and physical therapists who have been introduced to KneeMD universally agree that KneeMD should be used on 100% of patients recovering from TKA and other major knee surgeries. They also report improved patient compliance with therapy and an overall decrease in manipulation, with a subsequent increase in patient satisfaction.
A Company On The Move
Promotus is moving full speed ahead with KneeMD:
- Clinically Tested & Market Ready – Patented, FDA-registered and available for order
- Physician and Physical Therapist-Approved – Devices in active use in orthopedic and physical therapy clinics support KneeMD’s effectiveness and market need with patients who have undergone major knee surgeries
Find Out More About KneeMD
Contact
KneeMD
Email: info@kneemd.co
1-805-864-2742, or 1-800-385-3592
1OrthoWorld. The Orthopaedic Industry Annual Report 2010-2011.
2Sharkey PF, et al., Insall Award paper. Why are total knee arthroplasties failing today? Clin Orthop Relat Res, 2002(404): p. 7-13.